Stonepine Capital Management, LLC Aclaris Therapeutics, Inc. Transaction History
Stonepine Capital Management, LLC
- $103 Billion
- Q1 2025
A detailed history of Stonepine Capital Management, LLC transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, Stonepine Capital Management, LLC holds 527,842 shares of ACRS stock, worth $802,319. This represents 2.69% of its overall portfolio holdings.
Number of Shares
527,842
Previous 663,405
20.43%
Holding current value
$802,319
Previous $1.65 Billion
68.13%
% of portfolio
2.69%
Previous 1.33%
Shares
4 transactions
Others Institutions Holding ACRS
# of Institutions
112Shares Held
92.9MCall Options Held
35.4KPut Options Held
32K-
Bml Capital Management, LLC Zionsville, IN14.3MShares$21.7 Million17.65% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA9.63MShares$14.6 Million0.03% of portfolio
-
Vivo Capital, LLC Palo Alto, CA8.89MShares$13.5 Million3.69% of portfolio
-
Rock Springs Capital Management LP Baltimore, MD5.05MShares$7.67 Million0.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.97MShares$7.55 Million0.0% of portfolio
About Aclaris Therapeutics, Inc.
- Ticker ACRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 66,671,800
- Market Cap $101M
- Description
- Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...